Cardioprotective effects of coffee
DOI:
https://doi.org/10.12775/JEHS.2022.12.10.004Keywords
coffee, atrial fibrillation, chlorogenic acid, caffeine, cardioprotectionAbstract
Coffee is one of the most consumed beverages among adults. Popular for its stimulant properties, it is also appreciated for its taste and is an essential part of many people's daily lives. Coffee, in addition to caffeine, contains macroelements such as sodium, potassium and magnesium, which ensure the proper functioning of the body, as well as polyphenols which are characterised by their anti-inflammatory properties. [1,2] Atrial fibrillation is the most common arrhythmia and caffeine is often considered a potential risk factor. [3] The purpose of this article is to evaluate current scientific reports on the relationship between coffee consumption and atrial fibrillation.
References
Olechno E, Puścion-Jakubik A, Socha K, Zujko ME. Coffee Brews: Are They a Source of Macroelements in Human Nutrition? Foods. 2021 Jun 9;10(6):1328. doi: 10.3390/foods10061328. PMID: 34207680; PMCID: PMC8227654.
Godos, J., Pluchinotta, F. R., Marventano, S., Buscemi, S., Li Volti, G., Galvano, F., & Grosso, G. (2014). Coffee components and cardiovascular risk: beneficial and detrimental effects. International Journal of Food Sciences and Nutrition, 65(8), 925–936. doi:10.3109/09637486.2014.940287
Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014 Apr 25;114(9):1453-68. doi: 10.1161/CIRCRESAHA.114.303211. PMID: 24763464.
Rashidinejad, A., Tarhan, O., Rezaei, A., Capanoglu, E., Boostani, S., Khoshnoudi-Nia, S., … Jafari, S. M. (2021). Addition of milk to coffee beverages; the effect on functional, nutritional, and sensorial properties. Critical Reviews in Food Science and Nutrition, 1–21. doi:10.1080/10408398.2021.1897516
Institute of Medicine (US) Committee on Military Nutrition Research. Caffeine for the Sustainment of Mental Task Performance: Formulations for Military Operations. Washington (DC): National Academies Press (US); 2001. 2, Pharmacology of Caffeine. Available from: https://www.ncbi.nlm.nih.gov/books/NBK223808/
Duncan Turnbull, Joseph V. Rodricks, Gregory F. Mariano, Farah Chowdhury, Caffeine and cardiovascular health,Regulatory Toxicology and Pharmacology, Volume 89, 2017, Pages 165-185, ISSN 0273-2300, https://doi.org/10.1016/j.yrtph.2017.07.025.
Rodak K, Kokot I, Kratz EM. Caffeine as a Factor Influencing the Functioning of the Human Body—Friend or Foe? Nutrients. 2021; 13(9):3088. https://doi.org/10.3390/nu13093088
Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res. 2017 Apr 28;120(9):1501-1517. doi: 10.1161/CIRCRESAHA.117.309732. PMID: 28450367; PMCID: PMC5500874.
Maria Trusz-Gluza, Wiktoria Leśniak, Migotanie przedsionków (AF), s.216-224, W: Interna Szczeklika, red. Gajewski P, Medycyna Praktyczna, Kraków 2019
Rienstra M, Lubitz SA, Mahida S, Magnani JW, Fontes JD, Sinner MF, Van Gelder IC, Ellinor PT, Benjamin EJ. Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation. 2012 Jun 12;125(23):2933-43. doi: 10.1161/CIRCULATIONAHA.111.069450. PMID: 22689930; PMCID: PMC3402179.
Steinberg BA, Kim S, Thomas L, Fonarow GC, Gersh BJ, Holmqvist F, Hylek E, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel JA, Chang P, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF) Investigators and Patients. Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF). J Am Heart Assoc. 2015 Sep 14;4(9):e002031. doi: 10.1161/JAHA.115.002031. PMID: 26370445; PMCID: PMC4599492.
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612. Erratum in: Eur Heart J. 2021 Feb 1;42(5):507. Erratum in: Eur Heart J. 2021 Feb 1;42(5):546-547. Erratum in: Eur Heart J. 2021 Oct 21;42(40):4194. PMID: 32860505.
Christophersen IE, Ellinor PT. Genetics of atrial fibrillation: from families to genomes. J Hum Genet. 2016 Jan;61(1):61-70. doi: 10.1038/jhg.2015.44. Epub 2015 May 21. PMID: 25994868.
Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A, Jonasdottir A, Baker A, Thorleifsson G, Kristjansson K, Palsson A, Blondal T, Sulem P, Backman VM, Hardarson GA, Palsdottir E, Helgason A, Sigurjonsdottir R, Sverrisson JT, Kostulas K, Ng MC, Baum L, So WY, Wong KS, Chan JC, Furie KL, Greenberg SM, Sale M, Kelly P, MacRae CA, Smith EE, Rosand J, Hillert J, Ma RC, Ellinor PT, Thorgeirsson G, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature. 2007 Jul 19;448(7151):353-7. doi: 10.1038/nature06007. Epub 2007 Jul 1. PMID: 17603472.
Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, Seshadri S, Wolf PA, Vasan RS, Benjamin EJ, Levy D. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.Lancet. 2015; 386:154–162. doi: 10.1016/S0140-6736(14)61774-8.
Murphy NF, Simpson CR, Jhund PS, Stewart S, Kirkpatrick M, Chalmers J, MacIntyre K, McMurray JJ. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland.Heart. 2007; 93:606–612. doi: 10.1136/hrt.2006.107573
Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005 Dec 7;105(3):315-8. doi: 10.1016/j.ijcard.2005.02.050. PMID: 16274775.
Huxley RR, Filion KB, Konety S, Alonso A. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.Am J Cardiol. 2011; 108:56–62. doi: 10.1016/j.amjcard.2011.03.004
Alonso A, Krijthe BP, Aspelund T, et al.. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.J Am Heart Assoc. 2013; 2:e000102. doi: 10.1161/JAHA.112.000102.
Verdecchia P, Angeli F, Reboldi G. Hypertension and Atrial Fibrillation: Doubts and Certainties From Basic and Clinical Studies. Circ Res. 2018 Jan 19;122(2):352-368. doi: 10.1161/CIRCRESAHA.117.311402. PMID: 29348255.
Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, Sahadevan J, Redline S; Sleep Heart Health Study. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med. 2006 Apr 15;173(8):910-6. doi: 10.1164/rccm.200509-1442OC. Epub 2006 Jan 19. PMID: 16424443; PMCID: PMC2662909.
Wang TJ, Parise H, Levy D, D’Agostino RB, Wolf PA, Vasan RS, Benjamin EJ. Obesity and the risk of new-onset atrial fibrillation.JAMA. 2004; 292:2471–2477. doi: 10.1001/jama.292.20.2471
Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJ. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J. 2006 Jan;27(1):96-106. doi: 10.1093/eurheartj/ehi506. Epub 2005 Sep 23. PMID: 16183687.
Diouf I, Magliano DJ, Carrington MJ, Stewart S, Shaw JE. Prevalence, incidence, risk factors and treatment of atrial fibrillation in Australia: The Australian Diabetes, Obesity and Lifestyle (AusDiab) longitudinal, population cohort study. Int J Cardiol. 2016 Feb 15;205:127-132. doi: 10.1016/j.ijcard.2015.12.013. Epub 2015 Dec 15. PMID: 26730844.
Mohanty S, Mohanty P, Tamaki M, Natale V, Gianni C, Trivedi C, Gokoglan Y, DI Biase L, Natale A. Differential Association of Exercise Intensity With Risk of Atrial Fibrillation in Men and Women: Evidence from a Meta-Analysis. J Cardiovasc Electrophysiol. 2016 Sep;27(9):1021-9. doi: 10.1111/jce.13023. Epub 2016 Jul 7. PMID: 27245609.
Heeringa J, Kors JA, Hofman A, van Rooij FJ, Witteman JC. Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study. Am Heart J. 2008 Dec;156(6):1163-9. doi: 10.1016/j.ahj.2008.08.003. Epub 2008 Oct 14. PMID: 19033014.
O’Neal WT, Qureshi WT, Judd SE, McClure LA, Cushman M, Howard VJ, Howard G, Soliman EZ. Environmental tobacco smoke and atrial fibrillation: the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study.J Occup Environ Med. 2015; 57:1154–1158. doi: 10.1097/JOM.0000000000000565.
Bodar V, Chen J, Gaziano JM, Albert C, Djoussé L. Coffee Consumption and Risk of Atrial Fibrillation in the Physicians' Health Study. J Am Heart Assoc. 2019 Aug 6;8(15):e011346. doi: 10.1161/JAHA.118.011346. Epub 2019 Aug 5. PMID: 31378120; PMCID: PMC6761675.
Cao Y, Liu X, Xue Z, Yin K, Ma J, Zhu W, Liu F, Luo J, Sun J. Association of Coffee Consumption With Atrial Fibrillation Risk: An Updated Dose-Response Meta-Analysis of Prospective Studies. Front Cardiovasc Med. 2022 Jul 6;9:894664. doi: 10.3389/fcvm.2022.894664. PMID: 35872898; PMCID: PMC9299433.
Mostofsky E, Johansen MB, Lundbye-Christensen S, Tjønneland A, Mittleman MA, Overvad K. Risk of atrial fibrillation associated with coffee intake: Findings from the Danish Diet, Cancer, and Health study. Eur J Prev Cardiol. 2016 Jun;23(9):922-30. doi: 10.1177/2047487315624524. Epub 2015 Dec 23. PMID: 26701875; PMCID: PMC6026854.
Godoy-Marín H, Duroux R, Jacobson KA, Soler C, Colino-Lage H, Jiménez-Sábado V, Montiel J, Hove-Madsen L, Ciruela F. Adenosine A2A Receptors Are Upregulated in Peripheral Blood Mononuclear Cells from Atrial Fibrillation Patients. Int J Mol Sci. 2021 Mar 27;22(7):3467. doi: 10.3390/ijms22073467. PMID: 33801676; PMCID: PMC8036820.
Xu J, Fan W, Budoff MJ, Heckbert SR, Amsterdam EA, Alonso A, Wong ND. Intermittent Nonhabitual Coffee Consumption and Risk of Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis. J Atr Fibrillation. 2019 Jun 30;12(1):2205. doi: 10.4022/jafib.2205. PMID: 31687073; PMCID: PMC6811341.
Korantzopoulos P, Letsas KP, Tse G, Fragakis N, Goudis CA, Liu T. Inflammation and atrial fibrillation: A comprehensive review. J Arrhythm. 2018 Jun 4;34(4):394-401. doi: 10.1002/joa3.12077. PMID: 30167010; PMCID: PMC6111477.
Reis CEG, Dórea JG, da Costa THM. Effects of coffee consumption on glucose metabolism: A systematic review of clinical trials. J Tradit Complement Med. 2018 May 3;9(3):184-191. doi: 10.1016/j.jtcme.2018.01.001. PMID: 31193893; PMCID: PMC6544578.
Ong KW, Hsu A, Tan BK. Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation. Biochem Pharmacol. 2013 May 1;85(9):1341-51. doi: 10.1016/j.bcp.2013.02.008. Epub 2013 Feb 14. PMID: 23416115.
Cano-Marquina A, Tarín JJ, Cano A. The impact of coffee on health. Maturitas. 2013 May;75(1):7-21. doi: 10.1016/j.maturitas.2013.02.002. Epub 2013 Mar 5. PMID: 23465359.
Nohara-Shitama Y, Adachi H, Enomoto M, Fukami A, Nakamura S, Kono S, Morikawa N, Sakaue A, Hamamura H, Toyomasu K, Fukumoto Y. Habitual coffee intake reduces all-cause mortality by decreasing heart rate. Heart Vessels. 2019 Nov;34(11):1823-1829. doi: 10.1007/s00380-019-01422-0. Epub 2019 May 6. PMID: 31062117.
Socała K, Szopa A, Serefko A, Poleszak E, Wlaź P. Neuroprotective Effects of Coffee Bioactive Compounds: A Review. Int J Mol Sci. 2020 Dec 24;22(1):107. doi: 10.3390/ijms22010107. PMID: 33374338; PMCID: PMC7795778.
Kolahdouzan M, Hamadeh MJ. The neuroprotective effects of caffeine in neurodegenerative diseases. CNS Neurosci Ther. 2017 Apr;23(4):272-290. doi: 10.1111/cns.12684. PMID: 28317317; PMCID: PMC6492672.
Glatter KA, Myers R, Chiamvimonvat N. Recommendations regarding dietary intake and caffeine and alcohol consumption in patients with cardiac arrhythmias: what do you tell your patients to do or not to do? Curr Treat Options Cardiovasc Med. 2012 Oct;14(5):529-35. doi: 10.1007/s11936-012-0193-6. PMID: 22865244; PMCID: PMC3742445.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Anna Karaś, Kinga Kawałko, Kamil Pondel, Krzysztof Bielewicz
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 590
Number of citations: 0
